期刊文献+

检测关节液MMP-3对颞下颌关节紊乱病诊断的意义

Value of Joint Fluid MMP-3 in Diagnosis of TMD
下载PDF
导出
摘要 目的:探讨颞下颌关节紊乱病(TMD)患者关节液中基质金属蛋白酶-3(MMP-3)与关节病变程度的关系。方法:留取115例TMD患者符合标准的126侧关节和健康志愿者32侧关节关节液标本。患者标本依据临床和TM J影像学检查,分为①关节炎症性疾病(C/S)组(n=24);②结构紊乱(ID)组(n=58);③骨关节病(OA)组(n=44);④健康志愿者关节液设为对照组(n=32)。用ELISA法检测关节液标本中MMP-3含量。结果:OA组MMP-3含量为(74.677±46.910)ng/m l(32/44),ID组为(49.086±22.298)ng/m l(20/58),C/S组为(32.609±9.470)ng/m l(7/24),对照组含量为(23.663±8.767)ng/m l(14/32)。OA组、ID组与C/S组及对照组比较有显著差异(P<0.05);ID组、C/S组与对照组比较亦有显著差异(P<0.05)。结论:MMP-3直接参与了TM J关节组织的病理破坏过程;关节液中MMP-3的水平反映了TMD病变的严重程度;关节液中的MMP-3可以作为一个反映TMD关节损害和代谢的重要分子标志。 Objective :To investigate the relationship between the concentration of matrix metalloproteinase-3 (MMP-3) in synovial fluid and the degree of tissue lesion in TMJs from patients with TMD. Methods:Samples from 126 TMJs in TMD patients were divided into three groups according to clinical examination and imaging findings : ① Capsulitis/Synovitis (C/S) group ( n=24 ) ; ②Internal derangement (ID) group (n = 58 ) ; ③ Osteoarthritis (OA) group (n=44). ④Samples from asymptomatic volunteers served as control group (n=32). The concentration of MMP-3 in TMJ synovial fluid was measured using Enzyme-linked -immunosorbent-assay (ELISA). ResuIts: The level of MMP-3 in OA group (74. 677±46. 910)ng/ml, was significantly higher than that in ID group (49. 086±22. 298 )ng/ml, C/S group (32. 609±9. 470)ng/ml and control group (23.663±8.767 )ng/ml ( P 〈 0.05 ). Both the levels of MMP-3 in ID group and C/S group were significantly higher than that in control group (P〈0.05 ). ConcIusion: MMP-3 was involved in the pathogenesis of TMD. The level of MMP-3 in synovial fluid could reflect the degree of lesion of TMJs.
出处 《华北国防医药》 2006年第2期92-94,共3页 Medical Journal of Beijing Military Region
基金 北京军区"十五"医学科学技术研究资助项目(No.02B011)
关键词 颞下颌关节紊乱病 关节液 基质金属蛋白酶-3 诊断 Temporomandibular disorder Synovial fluid Matrix metalloproteinase-3 Diagnosis
  • 相关文献

参考文献8

  • 1Alstergren P,Kopp S,Theodorsson E.Synovial fluid sampling from the temporomandibular joint:sample quality criteria and levels of interleukin -1β-and serotonin[J].Acta Odontol Scand,1999,57:16-22.
  • 2秦力铮,龙星.基质金属蛋白酶与颞下颌关节紊乱病[J].国外医学(口腔医学分册),2003,30(1):16-17. 被引量:3
  • 3Kubota E,Kubata T,Matsumoto J,et al.Synovial fuid cytokines and proteinase as markers of temporomandibular joint disease[J].J Oral Maxillofac Surg,1998,56:192-198.
  • 4Ishimaru JI,Oguma Y,Goss AN.Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and lavage synovial fluid of patients with temporomandibular joint disoders[J].Br J Oral Maxillofac Surg,2000,38:354-359.
  • 5Kubota T,Kubota E,Matsumoto A,et al.Identification of matrix metalloproteinases (MMPs) in synovial fluid from patients with temporomandbular disorder[J].Eur J Oral Sci,1998,106:992-998.
  • 6Brikedal-Hansen H,Werb Z,Welgus H,et al.Matrix metalloproteinases and inhibitors[C].Stuttgart:Fischer,1992.37-44.
  • 7Kubota E,Imamura H,Kubota T,et al.Interleukin 1 β and stromelysin(MMP-3) activity of synovial fluid as possible markers of osteoarthritis in the temporomandbular joint[J].J Oral Maxillofac Surg,1997,55:20-27.
  • 8Kanyama M,Kuboki T,Kojima S,et al.Matrix metalloproteinases and tissue inhibitors of metallo proteinases in synovial fluid patients with temporomandibular joint osteoarthritis[J].J Orofac Pain,2000,14:20-30.

二级参考文献3

  • 1Dijkgraaf LC, de Boat LG, Boering G. J Oral Maxillofac Sag,1995, 53(3):924-929
  • 2Nagase H, Woessner .IT Jr. J Biol Chem, 1999, 274(31) : 21491-21494
  • 3Pei D, Weiss SJ. J Biol Chem, 1996, 271(15):9135-9140

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部